Time-dependent kinetics of lignocaine in the isolated perfused rat liver
- PMID: 6886972
- DOI: 10.1007/BF01061847
Time-dependent kinetics of lignocaine in the isolated perfused rat liver
Abstract
The kinetics of lignocaine have been investigated in the isolated perfused rat liver preparation. After a low dose (0.3 mg) the drug was eliminated according to first-order kinetics, but after higher doses (7.5, 15.0 mg) and multiple doses (3 X 1.5 mg at 15 min intervals), nonlinear kinetics were observed, which appeared to show time dependence. This was not due to deterioration of the preparation nor was there any evidence of a hepatotoxic effect of lignocaine. The kinetics of lignocaine were also found to be sex-dependent since it was eliminated at a faster rate by livers from male rats compared to those from female rats. Exogenous MEGX (7.5 mg), the mono-N-deethylated metabolite of lignocaine, inhibited the elimination of parent drug (1.5 mg dose). However, evidence was obtained suggesting that a direct effect of this and other end-product metabolites may not be responsible for the observed changes in lignocaine kinetics with time when the compounds are produced endogenously. Studies of the hepatic binding of lignocaine in the preparation showed the presence of high affinity-low capacity and low affinity-high capacity binding sites, which may be the enzymes responsible for aromatic hydroxylation and N-deethylation of the drug, respectively. Further experiments supported the view that an intermediate product of lignocaine, related to the N-deethylation pathway, might be inhibiting its further metabolism.
Similar articles
-
An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation.J Pharmacokinet Biopharm. 1986 Apr;14(2):107-30. doi: 10.1007/BF01065257. J Pharmacokinet Biopharm. 1986. PMID: 3746635
-
Inhibition of lignocaine metabolism by beta-adrenoceptor antagonists in rat and human liver microsomes.Xenobiotica. 1989 Sep;19(9):929-44. doi: 10.3109/00498258909043152. Xenobiotica. 1989. PMID: 2573201
-
Mechanisms of lidocaine kinetics in the isolated perfused rat liver. II. Kinetics of steady state elimination.Drug Metab Dispos. 1987 Jan-Feb;15(1):17-21. Drug Metab Dispos. 1987. PMID: 2881753
-
Clinical pharmacokinetics of lignocaine.Clin Pharmacokinet. 1978 May-Jun;3(3):177-201. doi: 10.2165/00003088-197803030-00001. Clin Pharmacokinet. 1978. PMID: 350470 Review.
-
Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.Acta Physiol Scand Suppl. 1995;627:1-42. Acta Physiol Scand Suppl. 1995. PMID: 8848946 Review.
Cited by
-
An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation.J Pharmacokinet Biopharm. 1986 Apr;14(2):107-30. doi: 10.1007/BF01065257. J Pharmacokinet Biopharm. 1986. PMID: 3746635
-
The pharmacokinetics and pharmacodynamics of lignocaine and MEGX in healthy subjects.J Pharmacokinet Biopharm. 1987 Apr;15(2):101-15. doi: 10.1007/BF01062338. J Pharmacokinet Biopharm. 1987. PMID: 3612496 Clinical Trial.
-
Effects of beta-adrenoceptor antagonists on the pharmacokinetics of lignocaine.Br J Clin Pharmacol. 1984;17 Suppl 1(Suppl 1):21S-28S. doi: 10.1111/j.1365-2125.1984.tb02424.x. Br J Clin Pharmacol. 1984. PMID: 6146336 Free PMC article.
-
Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainide.Med Toxicol Adverse Drug Exp. 1989 Nov-Dec;4(6):412-28. doi: 10.1007/BF03259923. Med Toxicol Adverse Drug Exp. 1989. PMID: 2513464 Review.